Table 2.

Clinical Outcomes^a,b

	Lenzilumab group (n=12)	Control group (n=27)	P
Incidence of clinical improvement	11 (91.7)	22 (81.5)	.43
Days to clinical improvement	5 (1-14)	11 (4-42)	.006
Days to discharge from hospital	5 (3-19)	11 (4-42)	.008
Mean temperature reduction, °C	1.075	0.459	.02
Days to resolution of fever	2 (1-6)	1 (1-3)	.22
Incidence of IMV	1 (8.3)	10 (37.0)	.10
Incidence of death	1 (8.3)	5 (18.5)	.43
Incidence of IMV and/or death	1 (8.3)	11 (40.7)	.07

^aIMV = invasive mechanical ventilation.

^bValues are n (%) unless otherwise noted.